fexofenadine
(RRJFVPUCXDGFJB-UHFFFAOYSA-N)
Structure
- SMILES
- OC(=O)C(c1ccc(cc1)C(CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O)O)(C)C.Cl
- Molecular Formula:
- C32H40ClNO4
- Molecular Weight:
- 538.117
- Log P:
- 6.2504
- Hydrogen Bond Acceptor:
- 5
- Hydrogen Bond Donor:
- 4
- TPSA:
- 81
- CAS Number(s):
- 138452-21-8; 153439-40-8
Synonym(s)
1.
fexofenadine
2.
Allegra
3.
MDL 16,455A
4.
MDL 16.455
5.
MDL 16455
6.
MDL-16455
7.
Telfast
8.
alpha-(4-(1-carboxy-1-methylethyl)phenyl)-4-hydroxydiphenylmethyl-1-piperidinebutanol
9.
fexofenadine hydrochloride
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Drug ineffective | FAERS: 4610 Canada Vigilance: 241 | Canada Vigilance US FAERS | |
| 2 | Extra dose administered | FAERS: 1163 | US FAERS | |
| 3 | Somnolence | FAERS: 523 Canada Vigilance: 22 | Canada Vigilance US FAERS | |
| 4 | Feeling abnormal | FAERS: 418 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 5 | Headache | FAERS: 409 Canada Vigilance: 28 | Canada Vigilance US FAERS | |
| 6 | Dizziness | FAERS: 308 Canada Vigilance: 14 | Canada Vigilance US FAERS | |
| 7 | Expired product administered | FAERS: 223 | US FAERS | |
| 8 | Product quality issue | FAERS: 216 | US FAERS | |
| 9 | Hypersensitivity | FAERS: 208 Canada Vigilance: 7 | Canada Vigilance US FAERS | |
| 10 | Malaise | FAERS: 207 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 11 | Drug effect incomplete | FAERS: 201 | US FAERS | |
| 12 | Unevaluable event | FAERS: 187 | US FAERS | |
| 13 | Wrong technique in product usage process | FAERS: 181 | US FAERS | |
| 14 | Sneezing | FAERS: 176 Canada Vigilance: 73 | Canada Vigilance US FAERS | |
| 15 | Pruritus | FAERS: 167 Canada Vigilance: 13 | Canada Vigilance US FAERS | |
| 16 | Nausea | FAERS: 149 Canada Vigilance: 25 | Canada Vigilance US FAERS | |
| 17 | Product use issue | FAERS: 149 | US FAERS | |
| 18 | Wrong technique in drug usage process | FAERS: 149 | US FAERS | |
| 19 | Fatigue | FAERS: 144 Canada Vigilance: 9 | Canada Vigilance US FAERS | |
| 20 | Overdose | FAERS: 135 | US FAERS | |
| 21 | Abdominal discomfort | FAERS: 119 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 22 | Urticaria | FAERS: 99 Canada Vigilance: 9 | Canada Vigilance US FAERS | |
| 23 | Adverse event | FAERS: 97 | US FAERS | |
| 24 | No adverse event | FAERS: 97 | US FAERS | |
| 25 | Vomiting | FAERS: 93 Canada Vigilance: 9 | Canada Vigilance US FAERS | |
| 26 | Intentional product misuse | FAERS: 90 | US FAERS | |
| 27 | Dysgeusia | FAERS: 89 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 28 | Accidental overdose | FAERS: 84 | US FAERS | |
| 29 | Product taste abnormal | FAERS: 83 | US FAERS | |
| 30 | Anxiety | FAERS: 78 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 31 | Back Pain | FAERS: 75 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 32 | Throat irritation | FAERS: 70 Canada Vigilance: 6 | Canada Vigilance US FAERS | |
| 33 | Drug dose omission | FAERS: 68 | US FAERS | |
| 34 | Palpitations | FAERS: 63 Canada Vigilance: 13 | Canada Vigilance US FAERS | |
| 35 | Pain | FAERS: 61 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 36 | Drug administration error | FAERS: 58 | US FAERS | |
| 37 | Nervousness | FAERS: 58 | US FAERS | |
| 38 | Nasopharyngitis | FAERS: 57 | US FAERS | |
| 39 | Oropharyngeal pain | FAERS: 57 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 40 | Constipation | FAERS: 51 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 41 | Epistaxis | FAERS: 50 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 42 | Inappropriate schedule of drug administration | FAERS: 47 | US FAERS | |
| 43 | Asthenia | FAERS: 42 | US FAERS | |
| 44 | Dyspepsia | FAERS: 42 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 45 | Incorrect dose administered | FAERS: 42 | US FAERS | |
| 46 | Drug ineffective for unapproved indication | FAERS: 41 | US FAERS | |
| 47 | Erythema | FAERS: 41 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 48 | Blood glucose increased | FAERS: 40 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 49 | Euphoric mood | FAERS: 40 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 50 | Feeling jittery | FAERS: 39 | US FAERS | |
| 51 | Visual Impairment | FAERS: 39 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 52 | Wrong drug administered | FAERS: 37 | US FAERS | |
| 53 | Drug effect delayed | FAERS: 36 | US FAERS | |
| 54 | Drug administered to patient of inappropriate age | FAERS: 32 | US FAERS | |
| 55 | Head discomfort | FAERS: 32 | US FAERS | |
| 56 | Product use complaint | FAERS: 31 | US FAERS | |
| 57 | Sinusitis | FAERS: 31 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 58 | Tremor | FAERS: 31 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 59 | Abdominal Pain | FAERS: 30 Canada Vigilance: 8 | Canada Vigilance US FAERS | |
| 60 | Product packaging issue | FAERS: 30 | US FAERS | |
| 61 | Product use in unapproved indication | FAERS: 30 | US FAERS | |
| 62 | Retching | FAERS: 30 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 63 | Chest discomfort | FAERS: 29 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 64 | Accidental exposure to product | FAERS: 28 | US FAERS | |
| 65 | Arthralgia | FAERS: 28 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 66 | Drug Dependence | FAERS: 28 | US FAERS | |
| 67 | Drug prescribing error | FAERS: 28 | US FAERS | |
| 68 | Lip swelling | FAERS: 28 | US FAERS | |
| 69 | Choking | FAERS: 27 | US FAERS | |
| 70 | Dysphonia | FAERS: 27 | US FAERS | |
| 71 | Myalgia | FAERS: 27 Canada Vigilance: 5 | Canada Vigilance US FAERS | |
| 72 | Vertigo | FAERS: 27 | US FAERS | |
| 73 | Asthma | FAERS: 26 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 74 | Chest Pain | FAERS: 26 Canada Vigilance: 7 | Canada Vigilance US FAERS | |
| 75 | Medication residue present | FAERS: 25 | US FAERS | |
| 76 | Memory impairment | FAERS: 25 | US FAERS | |
| 77 | Therapeutic response unexpected | FAERS: 24 | US FAERS | |
| 78 | Drug Tolerance | FAERS: 23 | US FAERS | |
| 79 | Accidental exposure to product by child | FAERS: 22 | US FAERS | |
| 80 | Eye irritation | FAERS: 22 Canada Vigilance: 11 | Canada Vigilance US FAERS | |
| 81 | Nasal discomfort | FAERS: 22 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 82 | Upper-airway cough syndrome | FAERS: 22 | US FAERS | |
| 83 | Ear discomfort | FAERS: 20 | US FAERS | |
| 84 | Medication Error | FAERS: 20 | US FAERS | |
| 85 | Therapeutic response delayed | FAERS: 20 | US FAERS | |
| 86 | Tinnitus | FAERS: 20 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 87 | Agitation | FAERS: 19 | US FAERS | |
| 88 | Productive Cough | FAERS: 19 | US FAERS | |
| 89 | Therapeutic reaction time decreased | FAERS: 19 | US FAERS | |
| 90 | Dehydration | FAERS: 18 | US FAERS | |
| 91 | Drug resistance | FAERS: 18 | US FAERS | |
| 92 | Flatulence | FAERS: 18 | US FAERS | |
| 93 | Tachycardia | FAERS: 18 Canada Vigilance: 9 | Canada Vigilance US FAERS | |
| 94 | Wheezing | FAERS: 18 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 95 | Alanine Aminotransferase Increased | FAERS: 16 | US FAERS | |
| 96 | Arthritis | FAERS: 16 | US FAERS | |
| 97 | Depressed mood | FAERS: 16 | US FAERS | |
| 98 | Discomfort | FAERS: 16 | US FAERS | |
| 99 | Lethargy | FAERS: 16 | US FAERS | |
| 100 | Swelling | FAERS: 16 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 101 | Ageusia | FAERS: 15 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 102 | Burning sensation | FAERS: 15 | US FAERS | |
| 103 | Chills | FAERS: 15 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 104 | Eye pain | FAERS: 15 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 105 | Nasal pruritus | FAERS: 15 | US FAERS | |
| 106 | Peripheral swelling | FAERS: 15 | US FAERS | |
| 107 | Amnesia | FAERS: 14 | US FAERS | |
| 108 | Atrial Fibrillation | FAERS: 14 | US FAERS | |
| 109 | Product complaint | FAERS: 14 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 110 | Sinus headache | FAERS: 14 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 111 | Aspartate Aminotransferase Increased | FAERS: 13 | US FAERS | |
| 112 | Cataract | FAERS: 13 | US FAERS | |
| 113 | Dry skin | FAERS: 13 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 114 | Musculoskeletal stiffness | FAERS: 13 | US FAERS | |
| 115 | Pharmaceutical product complaint | FAERS: 13 | US FAERS | |
| 116 | Choking sensation | FAERS: 12 | US FAERS | |
| 117 | Crying | FAERS: 12 | US FAERS | |
| 118 | Glaucoma | FAERS: 12 | US FAERS | |
| 119 | Disorientation | FAERS: 11 | US FAERS | |
| 120 | Dysuria | FAERS: 11 | US FAERS | |
| 121 | Eructation | FAERS: 11 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 122 | Multiple allergies | FAERS: 11 | US FAERS | |
| 123 | Ocular discomfort | FAERS: 11 | US FAERS | |
| 124 | Secretion discharge | FAERS: 11 | US FAERS | |
| 125 | Syncope | FAERS: 11 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 126 | Thirst | FAERS: 11 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 127 | Urinary tract infection | FAERS: 11 | US FAERS | |
| 128 | Alopecia | FAERS: 10 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 129 | Angioedema | FAERS: 10 | US FAERS | |
| 130 | Anosmia | FAERS: 10 | US FAERS | |
| 131 | Musculoskeletal Pain | FAERS: 10 | US FAERS | |
| 132 | Product physical issue | FAERS: 10 | US FAERS | |
| 133 | Sluggishness | FAERS: 10 | US FAERS | |
| 134 | Suicide attempt | FAERS: 10 | US FAERS | |
| 135 | Urinary Retention | FAERS: 10 | US FAERS | |
| 136 | Weight decreased | FAERS: 10 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 137 | Drug dispensing error | FAERS: 9 | US FAERS | |
| 138 | Eczema | FAERS: 9 | US FAERS | |
| 139 | Product difficult to swallow | FAERS: 9 | US FAERS | |
| 140 | Therapeutic response unexpected with drug substitution | FAERS: 9 | US FAERS | |
| 141 | jaundice | FAERS: 9 | US FAERS | |
| 142 | Acne | FAERS: 8 | US FAERS | |
| 143 | Anger | FAERS: 8 | US FAERS | |
| 144 | Flushing | FAERS: 8 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 145 | Hunger | FAERS: 8 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 146 | Poor quality sleep | FAERS: 8 | US FAERS | |
| 147 | Prescribed overdose | FAERS: 8 | US FAERS | |
| 148 | Product size issue | FAERS: 8 | US FAERS | |
| 149 | Product substitution issue | FAERS: 8 | US FAERS | |
| 150 | Restlessness | FAERS: 8 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 151 | Blood glucose decreased | FAERS: 7 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 152 | Cerebrovascular accident | FAERS: 7 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 153 | Circumstance or information capable of leading to medication error | FAERS: 7 | US FAERS | |
| 154 | Contraindicated product administered | FAERS: 7 | US FAERS | |
| 155 | Ear congestion | FAERS: 7 | US FAERS | |
| 156 | Epilepsy | FAERS: 7 | US FAERS | |
| 157 | Incorrect drug administration duration | FAERS: 7 | US FAERS | |
| 158 | Influenza | FAERS: 7 | US FAERS | |
| 159 | Pneumonia | FAERS: 7 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 160 | Product administration error | FAERS: 7 | US FAERS | |
| 161 | Shock | FAERS: 7 | US FAERS | |
| 162 | Viral upper respiratory tract infection | FAERS: 7 | US FAERS | |
| 163 | White blood cell count decreased | FAERS: 7 | US FAERS | |
| 164 | Arthropathy | FAERS: 6 | US FAERS | |
| 165 | Bronchitis | FAERS: 6 | US FAERS | |
| 166 | Chromaturia | FAERS: 6 | US FAERS | |
| 167 | Delirium | FAERS: 6 | US FAERS | |
| 168 | Diabetes Mellitus | FAERS: 6 | US FAERS | |
| 169 | Feeling of body temperature change | FAERS: 6 | US FAERS | |
| 170 | Impaired driving ability | FAERS: 6 | US FAERS | |
| 171 | Initial insomnia | FAERS: 6 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 172 | Irritable Bowel Syndrome | FAERS: 6 | US FAERS | |
| 173 | Limb injury | FAERS: 6 | US FAERS | |
| 174 | Macular degeneration | FAERS: 6 | US FAERS | |
| 175 | Mouth swelling | FAERS: 6 | US FAERS | |
| 176 | Oral pain | FAERS: 6 | US FAERS | |
| 177 | Oropharyngeal discomfort | FAERS: 6 | US FAERS | |
| 178 | Product dispensing error | FAERS: 6 | US FAERS | |
| 179 | Product dose omission | FAERS: 6 | US FAERS | |
| 180 | Product packaging quantity issue | FAERS: 6 | US FAERS | |
| 181 | Rash erythematous | FAERS: 6 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 182 | Renal pain | FAERS: 6 | US FAERS | |
| 183 | Rhabdomyolysis | FAERS: 6 | US FAERS | |
| 184 | Rhinalgia | FAERS: 6 | US FAERS | |
| 185 | Urine output increased | FAERS: 6 | US FAERS | |
| 186 | Anaphylactic shock | FAERS: 5 | US FAERS | |
| 187 | Asphyxia | FAERS: 5 | US FAERS | |
| 188 | Disability | FAERS: 5 | US FAERS | |
| 189 | Facial Pain | FAERS: 5 | US FAERS | |
| 190 | Hypotension | FAERS: 5 | US FAERS | |
| 191 | Lactose Intolerance | FAERS: 5 | US FAERS | |
| 192 | Laziness | FAERS: 5 | US FAERS | |
| 193 | Myocardial Infarction | FAERS: 5 | US FAERS | |
| 194 | Neck Pain | FAERS: 5 | US FAERS | |
| 195 | Product label issue | FAERS: 5 | US FAERS | |
| 196 | Product storage error | FAERS: 5 | US FAERS | |
| 197 | Reaction to drug excipients | FAERS: 5 | US FAERS | |
| 198 | Stevens-Johnson Syndrome | FAERS: 5 | US FAERS | |
| 199 | Stress | FAERS: 5 | US FAERS | |
| 200 | Therapeutic product effect incomplete | FAERS: 5 | US FAERS | |
| 201 | Therapeutic response changed | FAERS: 5 | US FAERS | |
| 202 | Upper respiratory tract congestion | FAERS: 5 | US FAERS | |
| 203 | Allergy to animal | FAERS: 4 | US FAERS | |
| 204 | Alopecia Areata | FAERS: 4 | US FAERS | |
| 205 | Blindness | FAERS: 4 | US FAERS | |
| 206 | Blood alkaline phosphatase increased | FAERS: 4 | US FAERS | |
| 207 | Blood creatine phosphokinase increased | FAERS: 4 | US FAERS | |
| 208 | Bradycardia | FAERS: 4 | US FAERS | |
| 209 | Cholestatic liver injury | FAERS: 4 | US FAERS | |
| 210 | Chronic sinusitis | FAERS: 4 | US FAERS | |
| 211 | Cystitis | FAERS: 4 | US FAERS | |
| 212 | Drug withdrawal syndrome | FAERS: 4 | US FAERS | |
| 213 | Epigastric discomfort | FAERS: 4 | US FAERS | |
| 214 | Expired drug administered | FAERS: 4 | US FAERS | |
| 215 | Exposure during breast feeding | FAERS: 4 | US FAERS | |
| 216 | Feeling Cold | FAERS: 4 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 217 | Food Allergy | FAERS: 4 | US FAERS | |
| 218 | Gamma-Glutamyltransferase Increased | FAERS: 4 | US FAERS | |
| 219 | Hepatitis | FAERS: 4 | US FAERS | |
| 220 | Hypervigilance | FAERS: 4 | US FAERS | |
| 221 | Intentional product use issue | FAERS: 4 | US FAERS | |
| 222 | Intercepted drug administration error | FAERS: 4 | US FAERS | |
| 223 | Joint swelling | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 224 | Laryngitis | FAERS: 4 | US FAERS | |
| 225 | Lymphadenopathy | FAERS: 4 | US FAERS | |
| 226 | Oral pruritus | FAERS: 4 | US FAERS | |
| 227 | Product solubility abnormal | FAERS: 4 | US FAERS | |
| 228 | Pulmonary congestion | FAERS: 4 | US FAERS | |
| 229 | Restless Legs Syndrome | FAERS: 4 | US FAERS | |
| 230 | Toothache | FAERS: 4 | US FAERS | |
| 231 | nervous system disorder | FAERS: 4 | US FAERS | |
| 232 | Agranulocytosis | FAERS: 3 | US FAERS | |
| 233 | Altered state of consciousness | FAERS: 3 | US FAERS | |
| 234 | Angina Pectoris | FAERS: 3 | US FAERS | |
| 235 | Aphasia | FAERS: 3 | US FAERS | |
| 236 | Aphonia | FAERS: 3 | US FAERS | |
| 237 | Blepharospasm | FAERS: 3 | US FAERS | |
| 238 | Blood potassium increased | FAERS: 3 | US FAERS | |
| 239 | Blood urine present | FAERS: 3 | US FAERS | |
| 240 | Bowel movement irregularity | FAERS: 3 | US FAERS | |
| 241 | Cheilitis | FAERS: 3 | US FAERS | |
| 242 | Cholestasis | FAERS: 3 | US FAERS | |
| 243 | Dementia | FAERS: 3 | US FAERS | |
| 244 | Depressed Level of Consciousness | FAERS: 3 | US FAERS | |
| 245 | Diplopia | FAERS: 3 | US FAERS | |
| 246 | Drug abuse | FAERS: 3 | US FAERS | |
| 247 | Drug effect variable | FAERS: 3 | US FAERS | |
| 248 | Drug effective for unapproved indication | FAERS: 3 | US FAERS | |
| 249 | Dystonia | FAERS: 3 | US FAERS | |
| 250 | Emotional disorder | FAERS: 3 | US FAERS | |
| 251 | Erectile dysfunction | FAERS: 3 | US FAERS | |
| 252 | Eye Infection | FAERS: 3 | US FAERS | |
| 253 | Fibromyalgia | FAERS: 3 | US FAERS | |
| 254 | Gluten sensitivity | FAERS: 3 | US FAERS | |
| 255 | Hypersomnia | FAERS: 3 | US FAERS | |
| 256 | Inappropriate schedule of product administration | FAERS: 3 | US FAERS | |
| 257 | Incorrect product storage | FAERS: 3 | US FAERS | |
| 258 | Incorrect route of drug administration | FAERS: 3 | US FAERS | |
| 259 | Increased viscosity of upper respiratory secretion | FAERS: 3 | US FAERS | |
| 260 | Infection | FAERS: 3 | US FAERS | |
| 261 | Laceration | FAERS: 3 | US FAERS | |
| 262 | Leukopenia | FAERS: 3 | US FAERS | |
| 263 | Middle insomnia | FAERS: 3 | US FAERS | |
| 264 | Mixed liver injury | FAERS: 3 | US FAERS | |
| 265 | Neutrophil count decreased | FAERS: 3 | US FAERS | |
| 266 | Pallor | FAERS: 3 | US FAERS | |
| 267 | Pancytopenia | FAERS: 3 | US FAERS | |
| 268 | Paranasal sinus discomfort | FAERS: 3 | US FAERS | |
| 269 | Product commingling | FAERS: 3 | US FAERS | |
| 270 | Product label confusion | FAERS: 3 | US FAERS | |
| 271 | Respiratory tract congestion | FAERS: 3 | US FAERS | |
| 272 | Rhinitis | FAERS: 3 Canada Vigilance: 44 | Canada Vigilance US FAERS | |
| 273 | Skin Papilloma | FAERS: 3 | US FAERS | |
| 274 | Snoring | FAERS: 3 | US FAERS | |
| 275 | Stomatitis | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 276 | Tension | FAERS: 3 | US FAERS | |
| 277 | Therapy non-responder | FAERS: 3 | US FAERS | |
| 278 | Ulcer | FAERS: 3 | US FAERS | |
| 279 | Urinary Incontinence | FAERS: 3 | US FAERS | |
| 280 | Wrong product administered | FAERS: 3 | US FAERS | |
| 281 | Abasia | FAERS: 2 | US FAERS | |
| 282 | Abnormal weight gain | FAERS: 2 | US FAERS | |
| 283 | Accidental exposure to product packaging | FAERS: 2 | US FAERS | |
| 284 | Alcohol interaction | FAERS: 2 | US FAERS | |
| 285 | Alopecia universalis | FAERS: 2 | US FAERS | |
| 286 | Aphthous Stomatitis | FAERS: 2 | US FAERS | |
| 287 | Apparent death | FAERS: 2 | US FAERS | |
| 288 | Asthenopia | FAERS: 2 | US FAERS | |
| 289 | Back disorder | FAERS: 2 | US FAERS | |
| 290 | Bladder pain | FAERS: 2 | US FAERS | |
| 291 | Blood cholesterol increased | FAERS: 2 | US FAERS | |
| 292 | Blood creatine increased | FAERS: 2 | US FAERS | |
| 293 | Blood glucose abnormal | FAERS: 2 | US FAERS | |
| 294 | Blood lactate dehydrogenase increased | FAERS: 2 | US FAERS | |
| 295 | Blood magnesium increased | FAERS: 2 | US FAERS | |
| 296 | Blood urea increased | FAERS: 2 | US FAERS | |
| 297 | Bronchospasm | FAERS: 2 | US FAERS | |
| 298 | Candidiasis | FAERS: 2 | US FAERS | |
| 299 | Cerebral Infarction | FAERS: 2 | US FAERS | |
| 300 | Cholecystitis | FAERS: 2 | US FAERS | |
| 301 | Cholelithiasis | FAERS: 2 | US FAERS | |
| 302 | Cold sweat | FAERS: 2 | US FAERS | |
| 303 | Dark circles under eyes | FAERS: 2 | US FAERS | |
| 304 | Deafness | FAERS: 2 | US FAERS | |
| 305 | Depression suicidal | FAERS: 2 | US FAERS | |
| 306 | Electrolyte imbalance | FAERS: 2 | US FAERS | |
| 307 | Enuresis | FAERS: 2 | US FAERS | |
| 308 | Facial paralysis | FAERS: 2 | US FAERS | |
| 309 | Formication | FAERS: 2 | US FAERS | |
| 310 | Gastritis | FAERS: 2 | US FAERS | |
| 311 | Gastrointestinal Pain | FAERS: 2 | US FAERS | |
| 312 | Hip surgery | FAERS: 2 | US FAERS | |
| 313 | Inability to afford medication | FAERS: 2 | US FAERS | |
| 314 | Inflammation | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 315 | Intentional self-injury | FAERS: 2 | US FAERS | |
| 316 | Intercepted drug prescribing error | FAERS: 2 | US FAERS | |
| 317 | Intestinal Obstruction | FAERS: 2 | US FAERS | |
| 318 | Leukocytosis | FAERS: 2 | US FAERS | |
| 319 | Limb discomfort | FAERS: 2 | US FAERS | |
| 320 | Lower respiratory tract infection | FAERS: 2 | US FAERS | |
| 321 | Mental impairment | FAERS: 2 | US FAERS | |
| 322 | Mood swings | FAERS: 2 | US FAERS | |
| 323 | Muscle tightness | FAERS: 2 | US FAERS | |
| 324 | Musculoskeletal discomfort | FAERS: 2 | US FAERS | |
| 325 | Nephrolithiasis | FAERS: 2 | US FAERS | |
| 326 | Neutropenia | FAERS: 2 | US FAERS | |
| 327 | Night sweats | FAERS: 2 | US FAERS | |
| 328 | Ocular icterus | FAERS: 2 | US FAERS | |
| 329 | Oral mucosal eruption | FAERS: 2 | US FAERS | |
| 330 | Paranasal sinus hypersecretion | FAERS: 2 | US FAERS | |
| 331 | Paranoia | FAERS: 2 | US FAERS | |
| 332 | Personality Change | FAERS: 2 | US FAERS | |
| 333 | Petechiae | FAERS: 2 | US FAERS | |
| 334 | Physical product label issue | FAERS: 2 | US FAERS | |
| 335 | Prescription drug used without a prescription | FAERS: 2 | US FAERS | |
| 336 | Product blister packaging issue | FAERS: 2 | US FAERS | |
| 337 | Product container issue | FAERS: 2 | US FAERS | |
| 338 | Product formulation issue | FAERS: 2 | US FAERS | |
| 339 | Product package associated injury | FAERS: 2 | US FAERS | |
| 340 | Product packaging difficult to open | FAERS: 2 | US FAERS | |
| 341 | Product physical consistency issue | FAERS: 2 | US FAERS | |
| 342 | Product shape issue | FAERS: 2 | US FAERS | |
| 343 | Psoriasis | FAERS: 2 | US FAERS | |
| 344 | Regurgitation | FAERS: 2 | US FAERS | |
| 345 | Rheumatoid Arthritis | FAERS: 2 | US FAERS | |
| 346 | Sinus operation | FAERS: 2 | US FAERS | |
| 347 | Skin test positive | FAERS: 2 | US FAERS | |
| 348 | Sleep Paralysis | FAERS: 2 | US FAERS | |
| 349 | Sudden death | FAERS: 2 | US FAERS | |
| 350 | Tachyphrenia | FAERS: 2 | US FAERS | |
| 351 | Tension Headache | FAERS: 2 | US FAERS | |
| 352 | Thermal burn | FAERS: 2 | US FAERS | |
| 353 | Thrombocytopenia | FAERS: 2 | US FAERS | |
| 354 | Toxic Epidermal Necrolysis | FAERS: 2 | US FAERS | |
| 355 | Toxicity to various agents | FAERS: 2 | US FAERS | |
| 356 | Tympanic Membrane Perforation | FAERS: 2 | US FAERS | |
| 357 | Violence-related symptom | FAERS: 2 | US FAERS | |
| 358 | Wrong dose | FAERS: 2 | US FAERS | |
| 359 | treatment failure | FAERS: 2 | US FAERS | |
| 360 | Accidental drug intake by child | FAERS: 1 | US FAERS | |
| 361 | Accidental exposure | FAERS: 1 | US FAERS | |
| 362 | Acquired Immunodeficiency Syndrome | FAERS: 1 | US FAERS | |
| 363 | Alcohol poisoning | FAERS: 1 | US FAERS | |
| 364 | Allergic sinusitis | FAERS: 1 | US FAERS | |
| 365 | Alopecia totalis | FAERS: 1 | US FAERS | |
| 366 | Anaphylactoid Reaction | FAERS: 1 | US FAERS | |
| 367 | Aneurysm | FAERS: 1 | US FAERS | |
| 368 | Anorexia | FAERS: 1 | US FAERS | |
| 369 | Apathy | FAERS: 1 | US FAERS | |
| 370 | Arteriosclerosis | FAERS: 1 | US FAERS | |
| 371 | Ascites | FAERS: 1 | US FAERS | |
| 372 | Atopy | FAERS: 1 | US FAERS | |
| 373 | Atrioventricular Block | FAERS: 1 | US FAERS | |
| 374 | Autonomic nervous system imbalance | FAERS: 1 | US FAERS | |
| 375 | Belligerence | FAERS: 1 | US FAERS | |
| 376 | Benign Prostatic Hyperplasia | FAERS: 1 | US FAERS | |
| 377 | Bladder spasm | FAERS: 1 | US FAERS | |
| 378 | Blood cortisol increased | FAERS: 1 | US FAERS | |
| 379 | Blood creatinine increased | FAERS: 1 | US FAERS | |
| 380 | Blood electrolytes abnormal | FAERS: 1 | US FAERS | |
| 381 | Blood immunoglobulin E increased | FAERS: 1 | US FAERS | |
| 382 | Blood iron increased | FAERS: 1 | US FAERS | |
| 383 | Blood potassium | FAERS: 1 | US FAERS | |
| 384 | Blood pressure fluctuation | FAERS: 1 | US FAERS | |
| 385 | Blood sodium | FAERS: 1 | US FAERS | |
| 386 | Blood triglycerides increased | FAERS: 1 | US FAERS | |
| 387 | Bradyphrenia | FAERS: 1 | US FAERS | |
| 388 | Bronchiectasis | FAERS: 1 | US FAERS | |
| 389 | Buccal mucosal roughening | FAERS: 1 | US FAERS | |
| 390 | Bursitis | FAERS: 1 | US FAERS | |
| 391 | Cardiac Flutter | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 392 | Cataract operation | FAERS: 1 | US FAERS | |
| 393 | Catatonia | FAERS: 1 | US FAERS | |
| 394 | Cerebral dysgenesis | FAERS: 1 | US FAERS | |
| 395 | Cheilosis | FAERS: 1 | US FAERS | |
| 396 | Chloasma | FAERS: 1 | US FAERS | |
| 397 | Chromatopsia | FAERS: 1 | US FAERS | |
| 398 | Clonus | FAERS: 1 | US FAERS | |
| 399 | Coating in mouth | FAERS: 1 | US FAERS | |
| 400 | Conjunctivitis | FAERS: 1 Canada Vigilance: 19 | Canada Vigilance US FAERS | |
| 401 | Contraindicated drug prescribed | FAERS: 1 | US FAERS | |
| 402 | Cyanosis | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 403 | Cyst | FAERS: 1 | US FAERS | |
| 404 | Cytopenia | FAERS: 1 | US FAERS | |
| 405 | Dacryostenosis acquired | FAERS: 1 | US FAERS | |
| 406 | Dental caries | FAERS: 1 | US FAERS | |
| 407 | Dermatitis | FAERS: 1 | US FAERS | |
| 408 | Diabetes mellitus inadequate control | FAERS: 1 | US FAERS | |
| 409 | Diaphragmalgia | FAERS: 1 | US FAERS | |
| 410 | Discontinued product administered | FAERS: 1 | US FAERS | |
| 411 | Disease recurrence | FAERS: 1 | US FAERS | |
| 412 | Diverticulitis | FAERS: 1 | US FAERS | |
| 413 | Diverticulum | FAERS: 1 | US FAERS | |
| 414 | Dose calculation error | FAERS: 1 | US FAERS | |
| 415 | Drooling | FAERS: 1 | US FAERS | |
| 416 | Drug exposure during pregnancy | FAERS: 1 | US FAERS | |
| 417 | Drug level increased | FAERS: 1 | US FAERS | |
| 418 | Drug screen false positive | FAERS: 1 | US FAERS | |
| 419 | Drug screen positive | FAERS: 1 | US FAERS | |
| 420 | Drug withdrawal headache | FAERS: 1 | US FAERS | |
| 421 | Dysarthria | FAERS: 1 | US FAERS | |
| 422 | Dysphemia | FAERS: 1 | US FAERS | |
| 423 | Economic problem | FAERS: 1 | US FAERS | |
| 424 | Electrocardiogram PQ interval prolonged | FAERS: 1 | US FAERS | |
| 425 | Electroencephalogram abnormal | FAERS: 1 | US FAERS | |
| 426 | Emergency Care | FAERS: 1 | US FAERS | |
| 427 | Encephalitis | FAERS: 1 | US FAERS | |
| 428 | Enlarged uvula | FAERS: 1 | US FAERS | |
| 429 | Eosinophilia | FAERS: 1 | US FAERS | |
| 430 | Epicondylitis | FAERS: 1 | US FAERS | |
| 431 | Eustachian tube disorder | FAERS: 1 | US FAERS | |
| 432 | Excessive eye blinking | FAERS: 1 | US FAERS | |
| 433 | Exophthalmos | FAERS: 1 | US FAERS | |
| 434 | Exposure to violent event | FAERS: 1 | US FAERS | |
| 435 | Fear of falling | FAERS: 1 | US FAERS | |
| 436 | Flank Pain | FAERS: 1 | US FAERS | |
| 437 | Foreign body aspiration | FAERS: 1 | US FAERS | |
| 438 | Foreign body in respiratory tract | FAERS: 1 | US FAERS | |
| 439 | Foreign body trauma | FAERS: 1 | US FAERS | |
| 440 | Full blood count abnormal | FAERS: 1 | US FAERS | |
| 441 | Gait inability | FAERS: 1 | US FAERS | |
| 442 | Gastric mucosal lesion | FAERS: 1 | US FAERS | |
| 443 | Gastric ulcer | FAERS: 1 | US FAERS | |
| 444 | Gastroenteritis | FAERS: 1 | US FAERS | |
| 445 | Gastrointestinal infection | FAERS: 1 | US FAERS | |
| 446 | Gastrointestinal motility disorder | FAERS: 1 | US FAERS | |
| 447 | Gastrointestinal perforation | FAERS: 1 | US FAERS | |
| 448 | Genital pain | FAERS: 1 | US FAERS | |
| 449 | Gingival erythema | FAERS: 1 | US FAERS | |
| 450 | Glossitis | FAERS: 1 | US FAERS | |
| 451 | Gout | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 452 | Granulocyte count decreased | FAERS: 1 | US FAERS | |
| 453 | Growth retardation | FAERS: 1 | US FAERS | |
| 454 | Hemiparesis | FAERS: 1 | US FAERS | |
| 455 | Hemiplegia | FAERS: 1 | US FAERS | |
| 456 | Hepatotoxicity | FAERS: 1 | US FAERS | |
| 457 | Hernia pain | FAERS: 1 | US FAERS | |
| 458 | Hypereosinophilic syndrome | FAERS: 1 | US FAERS | |
| 459 | Hyperventilation | FAERS: 1 | US FAERS | |
| 460 | Hypoaesthesia facial | FAERS: 1 | US FAERS | |
| 461 | Hypogeusia | FAERS: 1 | US FAERS | |
| 462 | Hypokinesia | FAERS: 1 | US FAERS | |
| 463 | Hypothyroidism | FAERS: 1 | US FAERS | |
| 464 | Idiopathic angioedema | FAERS: 1 | US FAERS | |
| 465 | Impatience | FAERS: 1 | US FAERS | |
| 466 | Incontinence | FAERS: 1 | US FAERS | |
| 467 | Incorrect drug dosage form administered | FAERS: 1 | US FAERS | |
| 468 | Incorrect product formulation administered | FAERS: 1 | US FAERS | |
| 469 | Increased bronchial secretion | FAERS: 1 | US FAERS | |
| 470 | Increased upper airway secretion | FAERS: 1 | US FAERS | |
| 471 | Insulin Resistance | FAERS: 1 | US FAERS | |
| 472 | Intellectual Disability | FAERS: 1 | US FAERS | |
| 473 | Intentional drug misuse | FAERS: 1 | US FAERS | |
| 474 | Investigation abnormal | FAERS: 1 | US FAERS | |
| 475 | Irregular breathing | FAERS: 1 | US FAERS | |
| 476 | Joint stiffness | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 477 | Laryngospasm | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 478 | Lymphocyte count decreased | FAERS: 1 | US FAERS | |
| 479 | Lymphocyte stimulation test positive | FAERS: 1 | US FAERS | |
| 480 | Lymphoma | FAERS: 1 | US FAERS | |
| 481 | MYELODYSPLASTIC SYNDROME | FAERS: 1 | US FAERS | |
| 482 | Macular fibrosis | FAERS: 1 | US FAERS | |
| 483 | Malabsorption from administration site | FAERS: 1 | US FAERS | |
| 484 | Mastocytosis | FAERS: 1 | US FAERS | |
| 485 | Maternal exposure during pregnancy | FAERS: 1 | US FAERS | |
| 486 | Medication residue | FAERS: 1 | US FAERS | |
| 487 | Menorrhagia | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 488 | Mental status changes | FAERS: 1 | US FAERS | |
| 489 | Metamorphopsia | FAERS: 1 | US FAERS | |
| 490 | Mouth Breathing | FAERS: 1 | US FAERS | |
| 491 | Muscle Fatigue | FAERS: 1 | US FAERS | |
| 492 | Muscle strain | FAERS: 1 | US FAERS | |
| 493 | Mycotic allergy | FAERS: 1 | US FAERS | |
| 494 | Myoglobinuria | FAERS: 1 | US FAERS | |
| 495 | Myositis | FAERS: 1 | US FAERS | |
| 496 | Narcolepsy | FAERS: 1 | US FAERS | |
| 497 | Nasal inflammation | FAERS: 1 | US FAERS | |
| 498 | Nasal mucosal disorder | FAERS: 1 | US FAERS | |
| 499 | Negative thoughts | FAERS: 1 | US FAERS | |
| 500 | Nerve injury | FAERS: 1 | US FAERS | |
| 501 | Neuralgia | FAERS: 1 | US FAERS | |
| 502 | Nodule | FAERS: 1 | US FAERS | |
| 503 | Nonspecific reaction | FAERS: 1 | US FAERS | |
| 504 | Obsessive thoughts | FAERS: 1 | US FAERS | |
| 505 | Oral discharge | FAERS: 1 | US FAERS | |
| 506 | Oropharyngeal blistering | FAERS: 1 | US FAERS | |
| 507 | Osteoporosis | FAERS: 1 | US FAERS | |
| 508 | Ovarian clear cell carcinoma | FAERS: 1 | US FAERS | |
| 509 | Overweight | FAERS: 1 | US FAERS | |
| 510 | Pain of skin | FAERS: 1 | US FAERS | |
| 511 | Panic Disorder | FAERS: 1 | US FAERS | |
| 512 | Perichondritis | FAERS: 1 | US FAERS | |
| 513 | Pharyngitis | FAERS: 1 | US FAERS | |
| 514 | Platelet count abnormal | FAERS: 1 | US FAERS | |
| 515 | Poisoning | FAERS: 1 | US FAERS | |
| 516 | Poor quality drug administered | FAERS: 1 | US FAERS | |
| 517 | Portal Hypertension | FAERS: 1 | US FAERS | |
| 518 | Post procedural complication | FAERS: 1 | US FAERS | |
| 519 | Presyncope | FAERS: 1 | US FAERS | |
| 520 | Product administered to patient of inappropriate age | FAERS: 1 | US FAERS | |
| 521 | Product closure issue | FAERS: 1 | US FAERS | |
| 522 | Product closure removal difficult | FAERS: 1 | US FAERS | |
| 523 | Product contamination | FAERS: 1 | US FAERS | |
| 524 | Product lot number issue | FAERS: 1 | US FAERS | |
| 525 | Product outer packaging issue | FAERS: 1 | US FAERS | |
| 526 | Product used for unknown indication | FAERS: 1 | US FAERS | |
| 527 | Prostatic Obstruction | FAERS: 1 | US FAERS | |
| 528 | Pulmonary Hypertension | FAERS: 1 | US FAERS | |
| 529 | Quadriplegia | FAERS: 1 | US FAERS | |
| 530 | Quality of life decreased | FAERS: 1 | US FAERS | |
| 531 | Rebound effect | FAERS: 1 | US FAERS | |
| 532 | Retinal Degeneration | FAERS: 1 | US FAERS | |
| 533 | Rheumatic disorder | FAERS: 1 | US FAERS | |
| 534 | Sarcoidosis | FAERS: 1 | US FAERS | |
| 535 | Scab | FAERS: 1 | US FAERS | |
| 536 | Scarlet Fever | FAERS: 1 | US FAERS | |
| 537 | Scleroderma | FAERS: 1 | US FAERS | |
| 538 | Sinus Tachycardia | FAERS: 1 | US FAERS | |
| 539 | Sinus pain | FAERS: 1 | US FAERS | |
| 540 | Skin irritation | FAERS: 1 | US FAERS | |
| 541 | Sleep Talking | FAERS: 1 | US FAERS | |
| 542 | Somnambulism | FAERS: 1 | US FAERS | |
| 543 | Spinal column stenosis | FAERS: 1 | US FAERS | |
| 544 | Spinal fusion surgery | FAERS: 1 | US FAERS | |
| 545 | Splenomegaly | FAERS: 1 | US FAERS | |
| 546 | Sputum retention | FAERS: 1 | US FAERS | |
| 547 | Squamous cell carcinoma of skin | FAERS: 1 | US FAERS | |
| 548 | Sudden onset of sleep | FAERS: 1 | US FAERS | |
| 549 | Superficial injury of eye | FAERS: 1 | US FAERS | |
| 550 | Supraventricular tachycardia | FAERS: 1 | US FAERS | |
| 551 | Suspected counterfeit product | FAERS: 1 | US FAERS | |
| 552 | Therapeutic procedure | FAERS: 1 | US FAERS | |
| 553 | Therapeutic product effect delayed | FAERS: 1 | US FAERS | |
| 554 | Therapeutic product ineffective for unapproved indication | FAERS: 1 | US FAERS | |
| 555 | Tinea Pedis | FAERS: 1 | US FAERS | |
| 556 | Tinea cruris | FAERS: 1 | US FAERS | |
| 557 | Tonsillectomy | FAERS: 1 | US FAERS | |
| 558 | Unexpected therapeutic drug effect | FAERS: 1 | US FAERS | |
| 559 | Urethral Stenosis | FAERS: 1 | US FAERS | |
| 560 | Urinary tract obstruction | FAERS: 1 | US FAERS | |
| 561 | Urine amphetamine positive | FAERS: 1 | US FAERS | |
| 562 | Vaginal Discharge | FAERS: 1 | US FAERS | |
| 563 | Ventricular Fibrillation | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 564 | Visual disturbance | FAERS: 1 | US FAERS | |
| 565 | Vitamin D Deficiency | FAERS: 1 | US FAERS | |
| 566 | Vulvovaginal burning sensation | FAERS: 1 | US FAERS | |
| 567 | Vulvovaginal dryness | FAERS: 1 | US FAERS | |
| 568 | Vulvovaginal pruritus | FAERS: 1 | US FAERS | |
| 569 | Wrong schedule | FAERS: 1 | US FAERS | |
| 570 | Yawning | FAERS: 1 | US FAERS | |
| 571 | furuncle | FAERS: 1 | US FAERS | |
| 572 | prostatitis | FAERS: 1 | US FAERS | |
| 573 | Dissociation | Canada Vigilance: 1 | Canada Vigilance | |
| 574 | Gingivitis | Canada Vigilance: 1 | Canada Vigilance | |
| 575 | Malabsorption | Canada Vigilance: 1 | Canada Vigilance | |
| 576 | Polyuria | Canada Vigilance: 1 | Canada Vigilance | |
| 577 | Skin reaction | Canada Vigilance: 1 | Canada Vigilance | |
| 578 | Tachyphylaxis | Canada Vigilance: 1 | Canada Vigilance | |
| 579 | Urine flow decreased | Canada Vigilance: 1 | Canada Vigilance |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.